These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 4824024)
21. Prescription drug advertising--should states regulate what is false and misleading? Shaeffer J Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454 [No Abstract] [Full Text] [Related]
22. Regulating pharmaceutical advertising: what will work? Shapiro MF CMAJ; 1997 Feb; 156(3):359-61. PubMed ID: 9033416 [TBL] [Abstract][Full Text] [Related]
23. The regulation of prescription drug advertising. Rheinstein RH; Hugstad PS Leg Med Annu; 1978; ():407-19. PubMed ID: 756944 [No Abstract] [Full Text] [Related]
24. 3. Drug regulations in Switzerland and their application. Hippenmeier F Bull Parenter Drug Assoc; 1974; 28(4):167-73. PubMed ID: 4855448 [No Abstract] [Full Text] [Related]
25. Medicine goes Madison Avenue: an evaluation of the effect of direct-to-consumer pharmaceutical advertising on the learned intermediary doctrine. Allen MC Spec Law Dig Health Care Law; 1998 Dec; (236):9-29. PubMed ID: 10187553 [No Abstract] [Full Text] [Related]
26. The regulatory morass: physicians' dealings with pharmaceutical manufacturers. Blehart B J Med Pract Manage; 2003; 19(3):164-5. PubMed ID: 14730825 [No Abstract] [Full Text] [Related]
27. QUAD routes out inferior drugs. Can Hosp; 1973 May; 50(5):58-9. PubMed ID: 4779804 [No Abstract] [Full Text] [Related]
28. Assessment of therapeutic equivalence in drug registration and control. Idänpään-Heikkilä J Ann Clin Res; 1974; 6(0):suppl 11:71-8. PubMed ID: 4850672 [No Abstract] [Full Text] [Related]
29. [Relationship between clinical pharmacology and pharmaceutical industry]. Ponec K Cas Lek Cesk; 1973 Jun; 112(26):821-8. PubMed ID: 4718381 [No Abstract] [Full Text] [Related]
34. Doctors are pivotal to prescription struggle. Chapman S Leg Aspects Med Pract; 1979 Mar; 7(3):42-4. PubMed ID: 423688 [No Abstract] [Full Text] [Related]
35. Generic vs. brand name drugs--quality, not cost, is key issue. Stetler CJ Internist; 1979 May; 20(4):9-10, 12. PubMed ID: 10242133 [No Abstract] [Full Text] [Related]
36. Use of generics will mean cost savings. Nelson G Internist; 1979 May; 20(4):6-8. PubMed ID: 10242132 [No Abstract] [Full Text] [Related]
37. What market values are doing to medicine. Relman AS Atlantic; 1992 Mar; 269(3):98-102, 105-106. PubMed ID: 11651349 [No Abstract] [Full Text] [Related]
38. Veterinary drug availability. Gloyd J J Am Vet Med Assoc; 1980 Apr; 176(7):611-4. PubMed ID: 7372533 [No Abstract] [Full Text] [Related]
39. Medicine and the pharmaceutical industry: a call to action. Stiles MM; Barrett B Am Fam Physician; 2007 May; 75(10):1447, 1451; discussion 1451. PubMed ID: 17555137 [No Abstract] [Full Text] [Related]
40. Personal use of drug samples by physicians and office staff. Margolis LH JAMA; 1997 Nov; 278(19):1567; author reply 1569. PubMed ID: 9370489 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]